Tudor Investment Corp’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.9K Buy
5,995
+4,555
+316% +$102K ﹤0.01% 3419
2026
Q1
$37.9K Buy
1,440
+815
+130% +$102K ﹤0.01% 3495
2025
Q4
$155K Sell
625
-1
-0.2% -$228 ﹤0.01% 3341
2025
Q3
$132K Buy
626
+45
+8% +$7.93K ﹤0.01% 3245
2025
Q2
$57.2K Hold
581
– – ﹤0.01% 3163
2025
Q1
$51.1K Hold
581
– – ﹤0.01% 2956
2024
Q4
$42K Hold
581
– – ﹤0.01% 2934
2024
Q3
$45.8K Hold
581
– – ﹤0.01% 2619
2024
Q2
$41.9K Hold
581
– – ﹤0.01% 2235
2024
Q1
$54.8K Hold
581
– – ﹤0.01% 2111
2023
Q4
$42.4K Hold
581
– – ﹤0.01% 2272
2023
Q3
$38.7K Hold
581
– – ﹤0.01% 2190
2023
Q2
$55.8K Hold
581
– – ﹤0.01% 2321
2023
Q1
$59K Buy
+581
New +$89K ﹤0.01% 2279
2022
Q4
– Sell
-586
Closed -$561K – 2561
2022
Q3
$561K Buy
+586
New +$582K 0.01% 1314
2021
Q2
– Sell
-451
Closed -$334K – 1713
2021
Q1
$334K Buy
451
+261
+137% +$211K 0.01% 1272
2020
Q4
$147K Buy
190
+27
+17% +$21.3K ﹤0.01% 1256
2020
Q3
$162K Buy
+163
New +$173K 0.01% 1151

Other funds holding GOSS

Tudor Investment Corp's GOSS Position: Q2 2026 in Review

Tudor Investment Corp increased its Gossamer Bio (GOSS) stake by 316% in Q2 2026, buying an estimated $102K and bringing the position to 5,995 shares worth $78.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3419.

Tudor Investment Corp first reported a position in GOSS in Q3 2020 and has held it in 18 quarters since. The position peaked at $561K in Q3 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Tudor Investment Corp held 5,995 shares of Gossamer Bio worth $78.9K as of Q2 2026.
  • Tudor Investment Corp bought 4,555 Gossamer Bio shares in Q2 2026, an estimated $102K.
  • Gossamer Bio made up ﹤0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #3419 holding.
  • Tudor Investment Corp first reported a position in Gossamer Bio in Q3 2020 and has held it in 18 quarters since.
  • Tudor Investment Corp's Gossamer Bio position peaked at $561K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.